CMS Ends Part D Standalone Drug Plan Subsidy Program After Two Years
The Centers for Medicare & Medicaid Services announced on July 28, 2026, that its Part D Premium Stabilization Demonstration will end after calendar year 2026, removing a subsidy that reduced average monthly standalone drug plan premiums by $26 in 2025 and $16 in 2026 for roughly 24.9 million enrollees. CMS has set the 2027 base beneficiary premium benchmark at $41.33, but individual plan premiums will not be known until the agency releases its landscape file in mid-to-late September, with open enrollment running October 15 through December 7. The program cost an estimated $9.8 billion across its two years, and while CMS expects most enrollees to see increases below $10 per month, that figure is an attributed expectation rather than a guaranteed ceiling.